title: Plasma HDL-cholesterol has an effect on nitric oxide production and arachidonic acid metabolism in the platelet membranes of coronary heart disease patients without LDL-hypercholesterolemia.
abstract: OBJECTIVE
  To evaluate nitric oxide (NO) production and [3H]arachidonic acid (AA) incorporation into platelet membranes of coronary artery disease (CAD) patients with/without HDL-hypocholesterolemia.
  
  
  METHODS
  16 healthy controls (C), 14 CAD patients with plasma HDL-hypocholesterolemia (nCAD) and 14--without HDL-hypocholesterolemia (nCAD). All subjects were without peripheral vascular disease and hypertension. The groups were matched for age, sex, BMI. The diagnosis of CAD was substantiated by coronary angiography.
  
  
  METHODS
  Nitric oxide end products xNO (NO2- plus NO3-) levels in the platelet membranes were measured using anion-exchange chromatography. [3H]AA release from labelled platelets was studied by the method of Neufeld and Majerus; radioactivity was measured by liquid scintillation counting. Levels of plasma HDL-cholesterol (HDL-Ch) and triglycerides were enzymatically determined.
  
  
  RESULTS
  Significant increase (mean +/- SD; Mann-Whitney U test) of [3H]AA incorporation into platelet membrane phospholipids was noted in CAD patients in comparison with healthy subjects (p < 0.001). A correlation (multiple regression analysis) was established between HDL-C level and [3H]AA (r = -0.58, p < 0.05, n = 28); and between HDL-Ch and NOx levels (r = 0.76, p < 0.05, n = 28) in CAD patients. CAD patients had lower NOx than healthy subjects (p < 0.0001), NOx was lower in the group with decreased HDL-Ch concentration (wCAD 36 +/- 5 vs. nCAD 42.3 +/- 6 mumol/mg, p < 0.002).
  
  
  CONCLUSIONS
  CAD patients show decreased ability to produce platelet-derived NO that leads to higher platelet sensitivity to aggregating stimuli. Decreased plasma HDL-Ch may affect AA metabolism and NO production in the platelet membranes of CAD patients without LDL-hypercholesterolemia.
authors.affiliation: Latvian Institute of Experimental and Clinical Medicine, Riga, Latvia. tretjako@latnet.lv
authors.forename: P
authors.initials: P
authors.lastname: Tretjakovs
authors.forename: U
authors.initials: U
authors.lastname: Kalnins
authors.forename: I
authors.initials: I
authors.lastname: Dabina
authors.forename: I
authors.initials: I
authors.lastname: Dinne
authors.forename: A
authors.initials: A
authors.lastname: Erglis
authors.forename: I
authors.initials: I
authors.lastname: Kumsars
authors.forename: A
authors.initials: A
authors.lastname: Jurka
mesh_terms: D016718:Arachidonic Acid / Q000378:metabolism*; D001792:Blood Platelets / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D003327:Coronary Disease / Q000097:blood* / Q000150:complications; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood* / Q000150:complications; D008297:Male; D008563:Membrane Lipids / Q000097:blood; D008875:Middle Aged; D009569:Nitric Oxide / Q000097:blood*; D009589:Nitrogen Oxides / Q000097:blood; D010743:Phospholipids / Q000097:blood; D012016:Reference Values; D012044:Regression Analysis; D014316:Tritium
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008563:Membrane Lipids; D009589:Nitrogen Oxides; D010743:Phospholipids; D014316:Tritium; D016718:Arachidonic Acid; D009569:Nitric Oxide